These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21778004)

  • 21. Quality of randomized controlled trials reporting in the primary treatment of brain tumors.
    Lai R; Chu R; Fraumeni M; Thabane L
    J Clin Oncol; 2006 Mar; 24(7):1136-44. PubMed ID: 16505433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of reporting in clinical trials of preharvest food safety interventions and associations with treatment effect.
    Sargeant JM; Saint-Onge J; Valcour J; Thompson A; Elgie R; Snedeker K; Marcynuk P
    Foodborne Pathog Dis; 2009 Oct; 6(8):989-99. PubMed ID: 19630508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine.
    Klassen TP; Pham B; Lawson ML; Moher D
    J Clin Epidemiol; 2005 Aug; 58(8):763-8. PubMed ID: 16018911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trials behind level A recommendations in obstetric practice bulletins: compliance with CONSORT statement.
    Chauhan SP; Berghella V; Sanderson M; Siddiqui D; Hendrix NW; Magann EF
    Am J Perinatol; 2009 Jan; 26(1):69-80. PubMed ID: 18979412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.
    Le Cleach L; Chassany O; Levy A; Wolkenstein P; Chosidow O
    Dermatology; 2008; 216(1):46-55. PubMed ID: 18032899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dealing with missing outcome data in randomized trials and observational studies.
    Groenwold RH; Donders AR; Roes KC; Harrell FE; Moons KG
    Am J Epidemiol; 2012 Feb; 175(3):210-7. PubMed ID: 22262640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of publication of randomized controlled trials in nephrology.
    Moorthi RN; Lam A; Tangri N; Sood MM; Wagner M; Alam A
    Clin Nephrol; 2013 Oct; 80(4):280-5. PubMed ID: 23782546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis.
    Currow DC; Plummer JL; Kutner JS; Samsa GP; Abernethy AP
    J Pain Symptom Manage; 2012 Oct; 44(4):595-603. PubMed ID: 22819439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intention-to-treat analyses in behavioral medicine randomized clinical trials.
    Pagoto SL; Kozak AT; John P; Bodenlos JS; Hedeker D; Spring B; Schneider KL
    Int J Behav Med; 2009; 16(4):316-22. PubMed ID: 19319693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Handling missing data in RCTs; a review of the top medical journals.
    Bell ML; Fiero M; Horton NJ; Hsu CH
    BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.
    Ibrahim F; Tom BD; Scott DL; Prevost AT
    Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Reporting Nutritional Randomized Controlled Trials in Patients With Cystic Fibrosis.
    Daitch V; Babich T; Singer P; Leibovici L
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):265-9. PubMed ID: 26881412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trial quality in nephrology: how are we measuring up?
    Palmer SC; Sciancalepore M; Strippoli GF
    Am J Kidney Dis; 2011 Sep; 58(3):335-7. PubMed ID: 21856491
    [No Abstract]   [Full Text] [Related]  

  • 34. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.
    Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó
    Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?
    Halimi JM; Sautenet B; Gatault P; Roland M; Giraudeau B
    Fundam Clin Pharmacol; 2012 Dec; 26(6):771-82. PubMed ID: 21851387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misuse and reporting of renal endpoints in randomized clinical trials.
    Halimi JM
    Am J Kidney Dis; 2012 Jan; 59(1):160; author reply 160-1. PubMed ID: 22177447
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing causal relationships between treatments and clinical outcomes: always read the fine print.
    Freidlin B; Korn EL
    Bone Marrow Transplant; 2012 May; 47(5):626-32. PubMed ID: 21625225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.
    Khan NA; Torralba KD; Aslam F
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34330848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.
    Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC;
    Trials; 2015 Aug; 16():364. PubMed ID: 26285819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.